SCHEMBL19960372

SCHEMBL19960372

O=Cc1ccccc1-c1cccc(Cl)c1Cl

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
LMNA P02545 1/20 0.46
THRB P10828 1/20 0.46
BLM P54132 1/20 0.46
ALDH1A1 P00352 3/20 0.45
TSHR P16473 1/20 0.39
TRIM24 O15164 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
ERN1 O75460 2/20 0.39
NOTUM Q6P988 2/20 0.38
IDO1 P14902 1/20 0.37
NUDT1 P36639 1/20 0.37
PPP1R15A O75807 1/20 0.36
MELK Q14680 1/20 0.36
PPP1R15B Q5SWA1 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1547476 0.85 TDP1 (0.52) TDP1MEN1KMT2ALMNATHRB
SCHEMBL10533687 0.84 TDP1 (0.46) TDP1MEN1KMT2ALMNATHRB
SCHEMBL19960392 0.83 CYP1A2 (0.42) TDP1MEN1KMT2ALMNATHRB
SCHEMBL28878312 0.82 TDP1 (0.43) TDP1MEN1KMT2ALMNATHRB
SCHEMBL10718432 0.82 TDP1 (0.48) TDP1MEN1KMT2ALMNATHRB
SCHEMBL11327375 0.81 TDP1 (0.43) TDP1MEN1KMT2ALMNATHRB
SCHEMBL2478161 0.81 ALDH1A1 (0.45) TDP1MEN1KMT2ALMNATHRB
SCHEMBL95211 0.81 ALDH1A1 (0.54) TDP1MEN1KMT2ALMNATHRB
SCHEMBL30011286 0.81 ALDH1A1 (0.54) TDP1MEN1KMT2ALMNATHRB
SCHEMBL6535649 0.80 TDP1 (0.46) TDP1MEN1KMT2ALMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2020-06-30 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-03-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180076395-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, PER2 TDP1 4181/4885MEN1 885/4885KMT2A 443/4885
US-10700289-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, PER2 TDP1 4181/4885MEN1 885/4885KMT2A 443/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.